A nurse is preparing to administer the influenza vaccine to a 65-year-old client. Which assessment finding would require the nurse to delay the vaccination?

Moderate to severe acute illness with fever is a contraindication for vaccination, requiring delay until recovery. Other options (mild shellfish allergy, normal temperature, recent pneumococcal vaccine) are not contraindications.

Understanding the Contraindications and Precautions for Influenza Vaccination

The decision to delay an influenza vaccination hinges on distinguishing between true contraindications, precautions, and invalid reasons to withhold the vaccine. For a 65-year-old client, the recommended vaccines are typically inactivated influenza vaccines (IIV) or recombinant influenza vaccine (RIV), not the live attenuated vaccine (LAIV) ^[1]. The core principle is that a moderate or severe acute illness, with or without fever, is a standard precaution for all vaccinations, including influenza.

Let's analyze why option 3 is the correct reason to delay, and why the other options are not.

* Option 1: Client reports a mild allergy to shellfish.
This is not a valid reason to delay. A shellfish allergy is a common misconception. Shellfish allergens are not components of influenza vaccines. The only allergy that constitutes a contraindication to inactivated influenza vaccines is a severe allergic reaction (e.g., anaphylaxis) to a previous dose of any influenza vaccine or to a vaccine component, such as egg protein for egg-based vaccines ^[1]. A mild allergy, especially to an unrelated substance like shellfish, does not preclude vaccination.

* Option 2: Client's temperature is 98.8°F (37.1°C).
This is a normal body temperature. A low-grade fever or a normal temperature is not a precaution. The guideline specifies that an acute illness must be moderate or severe to warrant postponement ^[1]. An afebrile, healthy state is the ideal time to administer the vaccine.

* Option 4: Client received a pneumococcal vaccine 2 weeks ago.
This is not a reason to delay. Inactivated influenza vaccines can be administered simultaneously with or at any interval before or after other inactivated or live vaccines. There is no required waiting period between an inactivated pneumococcal vaccine and an inactivated influenza vaccine ^[1]. Co-administration is a common and recommended practice to improve vaccination coverage.

* Option 3: Client reports having a moderate to severe acute illness with fever.
This is the correct reason to delay vaccination. The Advisory Committee on Immunization Practices (ACIP) identifies a moderate or severe acute illness with or without fever as a precaution for administering any vaccine, including the influenza vaccine ^[1]. The clinical rationale is twofold: first, to avoid superimposing vaccine-related adverse effects (like myalgia or fever) on the underlying illness, which would complicate the clinical picture; and second, to prevent the possibility that a fever developing after vaccination could be mistakenly attributed to the vaccine when it is actually a progression of the patient's acute illness. Once the acute episode of the illness has resolved, the vaccine can be safely administered.